Hypoglycemic and Hypolipidemic Effects of Leucine, Zinc, and Chromium, Alone and in Combination, in Rats with Type 2 Diabetes
Authors:
- 13 April 2017
- journal article
- research article
- Published by Springer Nature in Biological Trace Element Research
- Vol. 180 (2) , 246-254
Abstract
For the increasing development of diabetes, dietary habits and using appropriate supplements can play important roles in the treatment or reduction of risk for this disease. The objective of this study was to investigate the effects of leucine (Leu), zinc (Zn), and chromium (Cr) supplementation, alone or in combination, in rats with type 2 diabetes (T2D). Seventy-seven adult male Wistar rats were randomly assigned in 11 groups, using nutritional supplements and insulin (INS) or glibenclamide (GLC). Supplementing Leu significantly reduced blood glucose, triglycerides (TG), nonesterified fatty acids (NEFA), low-density lipoprotein (LDL), and increased high-density lipoprotein (HDL) concentrations compared to vehicle-treated T2D animals, and those improvements were associated with reduced area under the 2-h blood glucose response curve (AUC). Supplementation of T2D animals with Zn improved serum lipid profile as well as blood glucose concentrations but was not comparable with the INS, GLC, and Leu groups. Supplementary Cr did not improve blood glucose and AUC in T2D rats, whereas it reduced serum TG and LDL and increased HDL concentrations. In conclusion, supplementation of diabetic rats with Leu was more effective in improving blood glucose and consequently decreasing glucose AUC than other nutritional supplements. Supplementary Zn and Cr only improved serum lipid profile. The combination of the nutritional supplements did not improve blood glucose level. Nevertheless, supplementation with Leu-Zn, Leu-Cr, Zn-Cr, and Leu-Zn-Cr led to an improved response in serum lipid profile over each supplement given alone.Keywords
Funding Information
- Research Council of University of Tabriz, Iran
This publication has 56 references indexed in Scilit:
- The diabetes-susceptible gene SLC30A8/ZnT8 regulates hepatic insulin clearanceJournal of Clinical Investigation, 2013
- Effects of zinc supplementation on diabetes mellitus: a systematic review and meta-analysisDiabetology & Metabolic Syndrome, 2012
- Does Branched-Chain Amino Acids Supplementation Modulate Skeletal Muscle Remodeling through Inflammation Modulation? Possible Mechanisms of ActionJournal of Nutrition and Metabolism, 2012
- Dietary Leucine - An Environmental Modifier of Insulin Resistance Acting on Multiple Levels of MetabolismPLOS ONE, 2011
- Chronic leucine supplementation improves glycemic control in etiologically distinct mouse models of obesity and diabetes mellitusNutrition & Metabolism, 2010
- Body weight reduction in rats by oral treatment with zinc plus cyclo‐(His‐Pro)British Journal of Pharmacology, 2009
- A Branched-Chain Amino Acid-Related Metabolic Signature that Differentiates Obese and Lean Humans and Contributes to Insulin ResistanceCell Metabolism, 2009
- Efficacy and Safety Comparison of Liraglutide, Glimepiride, and Placebo, All in Combination With Metformin, in Type 2 DiabetesDiabetes Care, 2009
- Obesity-related elevations in plasma leucine are associated with alterations in enzymes involved in branched-chain amino acid metabolismAmerican Journal of Physiology-Endocrinology and Metabolism, 2007
- Chromium Oligopeptide Activates Insulin Receptor Tyrosine Kinase ActivityBiochemistry, 1997